Average Co-Inventor Count = 5.87
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (24 from 3,684 patents)
2. Enichem S.p.a (2 from 218 patents)
3. Saladax Biomedical Inc. (2 from 28 patents)
4. Other (1 from 832,843 patents)
29 patents:
1. 12097241 - Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides
2. 12097242 - Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides
3. 11952434 - Immunomodulators
4. 11364281 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof
5. 11358988 - Immunomodulators
6. 11185570 - Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides
7. 10823739 - Immunoassay standards and measurement of tau using intra-assay calibration standards
8. 10670612 - Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards
9. 10633419 - Immunomodulators
10. 10538555 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
11. 10450347 - Immunomodulators
12. 10266578 - Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
13. 9861680 - Immunomodulators
14. 9856292 - Immunomodulators
15. 9850283 - Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions